• Research Article
  • |
  • Open Access

SARS-CoV-2: An Ophthalmological Insight into the Pandemic; Challenges and Management Strategies

  • Jaya Kaushik;
    • Professor, Department of Ophthalmology, AFMC, Pune - 411048.
  • Sandeep Shankar;
    • Professor, Department of Ophthalmology, AFMC, Pune - 411048.
  • Anargh V;
    • Resident, Department of Ophthalmology, AFMC, Pune - 411048.
  • Renu M*;
    • Resident, Department of Ophthalmology, AFMC, Pune - 411048.
  • Ankita Singh;
    • Resident, Department of Ophthalmology, AFMC, Pune - 411048.
  • Rakesh Shetty
    • Resident, Department of Ophthalmology, AFMC, Pune - 411048.
  • Corresponding Author(s): Renu M

  • Resident, Department of Ophthalmology, Armed Forces Medical College, 1214, CHS, NIBM, Kondhwa, Pune, Maharashtra, PIN- 411048, India.

  • renumnair2@gmail.com

  • Renu M (2021).

  • This Article is distributed under the terms of Creative Commons Attribution 4.0 International License

Received : Sep 17, 2021
Accepted : Oct 06, 2021
Published Online : Oct 08, 2021
Journal : Annals of Ophthalmology and Visual Sciences
Publisher : MedDocs Publishers LLC
Online edition : http://meddocsonline.org

Cite this article: Kaushik J, Shankar S, Anargh V, Renu M, Singh A, et al. SARS-CoV-2: An Ophthalmological Insight into the Pandemic; Challenges and Management Strategies. Ann Ophthalmol Vis Sci. 2021; 4(1): 1017.

Abstract

      Objective: To formulate a protocol for safe and effective management of an ophthalmologic practice in a hospital or a clinic during the Covid - 19 pandemic.

      Methods and analysis: Literature was reviewed regarding Covid-19 pandemic and ophthalmology. The following key words were used. Covid-19, telemedicine, challenges, management strategy.

      Result: An efficient protocol for ophthalmology practice during the Covid-19 pandemic was established which covered various protective measures that are essential and vital in the Covid-19 pandemic.

      Conclusion: An evidence-based protocol was formulated which may be modified in future as per the latest developments and trends in the ongoing pandemic.

Introduction

      Since late 2019 and continuing for a foreseeable future, SARS-CoV2 has interrupted every aspect of medical care globally. From the preliminary period of the pandemic, ophthalmologists were at a high risk. The first physician to blow the whistle about COVID-19 causing human disease was the dauntless ophthalmologist Li-Wenliang, MD in Wuhan, China. Tragically he succumbed to the disease just weeks afterward heightening concerns within the ophthalmic community [1]. Since then, many reports have suggested that ophthalmologists may be at particular risk of infection perhaps due to proximity to patients, large numbers of patient interactions, spread through contact with infected secretions or the variable use of personal protective equipment [2,3].

      The recent pandemic lockdown has resulted in cancellation of many ophthalmologic visits and surgeries allowing only emergency services to be continued which could have potentially led to permanent and significant harm to patient’s vision [4]. A survey among public with eye diseases highlighted a significant negative psychosocial impact of lockdown on individuals with visual impairment and many of them expressing fear of further sight loss due to delayed review or treatment [5]. In developing eye care systems physicians face myriad difficult decisions. The number of patients overwhelms the capacity, deciding who receives treatment cannot simply be a question of diagnosis. Determining how to allocate care is agonizing, but necessary. Therefore, it is important that efficient measures are implemented during and after the Covid pandemic to avoid irreversible sight loss in eye disease which are vision threatening.

Challenges faced by ophthalmologists

Ophthalmologists are at a high risk due to various factors of which significant issues are discussed below.

1. Proximity to the patients during examination

      a. Proximity to the patients while examining in the clinic (conjunctival discharge, tears, nasal, or oral secretions can pose a hazard to ophthalmologists [6-8]. SARS-CoV-2 via its surface spike glycoprotein binds to the Angiotensin-Converting Enzyme 2 (ACE2) receptors. These ACE-2 receptors are found distributed in various human organs, including the surface of the cornea and the conjunctiva and these act as potential entry points [9,10]. Coronavirus was spotted in the conjunctival discharge of COVID-19 positive patients [11]. Loon et al have isolated virus from the tears of corona virus infected patients by Reverse Transcription Polymerase Chain Reaction (RT-PCR) [12]. There is potential risk of tears contaminating the fingers of the examiner and various equipment used.

      b. One of the main challenges faced by ophthalmologists is while using a direct ophthalmoscope which is crucial in the diagnosis of many conditions like papilledema, small bleeds, microaneurysms, microvascular abnormalities and other vascular changes which aid in the management of various ocular pathologies and also in examination of a patient with poor GCS where examination with an Indirect Ophthalmoscope is almost impossible. While using a direct ophthalmoscope, the doctor needs to be as close as 1.5cm to the patient for apt visualization of the fundus which poses a great danger to the examiner because of the close proximity to the patient where chances of spread of infection is very high.

      c. Yet another maneuver done routinely in an ophthalmology clinic is the evertion of eyelids which is done for visualization of the fornices, palpebral conjunctiva which are vital in the examination of a patient of conjunctivitis, foreign Body in eye, delineation of a hemorrhage and various other ocular pathologies. This maneuver increases chance of transmission of infection via ocular secretions if adequate precautions are not taken.

      d. Each patient visiting the ophthalmology clinic requires evaluation using multiple contact based equipment like autorefractometer, non-contact tonometer, slit lamp, IOL machines, OCT which require the patient to be aptly positioned by placement of chin on the chin rest and forehead touching the forehead rest. This acts as potential sources of infection both for other patients and also ophthalmologists.

2. Routine use of reusable equipments

      Ophthalmology is a unique practice requiring use of reusable equipment in close contact with patients and with many high-risk high-touch surfaces, thereby increasing the risk of transmission of the disease among patients [13]. Some of these equipment includes Goldmann Applanation Tonometer heads, Slit lamp Biomicroscopes, Humphrey Visual Field Analysers, Optical coherence Tomography, Specular microscopes, IOL Masters, Ultrasound Biomicroscope and even Trial frames and lenses which are routinely used in any ophthalmology clinic. Patients come in direct close contact with various parts of such instruments like chin rests, forehead rest and various probes provided with such instruments. This couple with the fact that corona viruses can survive up to 96 hours in biological fluids and in high relative humidity and low temperature makes contaminated surfaces key sources of iatrogenic transmission of infection [14-17].

3. Atypical symptoms

      Unfortunately, the covid-19 virus not only affects the respiratory tracts, but it may also manifest in other regions like the gastrointestinal tracts, and the ocular tissue as conjunctivitis has been reported during this outbreak. The conjunctival secretions yielded positive RT-PCR results in cases of conjunctivitis [18]. Eyecare professionals can also be caught unaware because conjunctivitis being one of the first signs of covid-19 at presentation [19].

Effective management strategy guidelines

      Covid -19 outbreak continues to challenge the healthcare ecosystem. The healthcare infrastructure needs to aim at early diagnosis of cases, increasing the testing protocols to increase the detection of cases and minimize the risk of transmission at all levels. Several measures to control infection were universally recommended and few manuscripts have detailed experience, gained during the ongoing corona virus pandemic [20-22].

      Infection control measures can be divided into 4 main categories. Use of PPE, General Infection control Measures and Administrative control.

1. Use of PPE

      With the stringent triaging and screening system in place, most of the routine patients coming for ophthalmologic consult would be at low risk for Covid -19. Current recommendations from the WHO and the CDC and prevention are use of PPE as a standard precautionary measure. The AAO and IOS have published a report advising ophthalmologists to wear masks and eye protection when seeing patients infected with Covid-19 [23,24].

2. General infection control

      To minimize the risk of contamination with respiratory droplets, tears and conjunctival secretions of infected patients; large protective plastic shields are being attached to slit lamps which acts as a barrier between the patient an ophthalmologist. IOS and AAO has also recommended such installation [23].

      Ophthalmic instruments can be a high source of virus contamination as patients often come in close contact with them. Routine disinfection/sterilization with the appropriate agents should be done. CDC recommended the use of disinfectants specific to COVID -19 including diluted household bleach (5 tablespoons of bleach per gallon of water and alcohol solutions with at least 70% alcohol) [25]. Disinfection of surfaces may also be performed using UV light, once manual chemical disinfection process is completed, to compensate for errors in manual disinfection process and thereby ensure a complete disinfection of the equipment and surfaces. Investigations have shown that 222-nm far-UVC light at low doses of between 1.7 and 1.2 mJ/cm2 inactivates 99.9% of aerosolized coronavirus though the SARS-Cov-2 strain was not specifically tested. Use in public locations at the current regulatory exposure limit (~3 mJ/cm2 /h) would result in approximately 90% viral inactivation in 8 min and 99.9% inactivation in ~25 min [26].

      It is also recommended to avoid the use of air puff to measure intraocular pressure to prevent the generation of aerosols from infected conjunctival secretions that risk transmission to healthcare workers [27].

      Lai et al reported the importance of air ventilation in waiting areas and suggested opening the fresh air dampers of the air handling equipment to achieve higher rate of fresh air with improved air dilution [20].

      It was also recommended that health care workers should wash their hands with combination of chlorhexidine with ethanol and cetrimide, or hand rub with alcohol based solutions and routinely clean “high-touch surfaces” after every patient [23].

3. Administrative measures

      This is the most important step adopted to reduce risk of exposure of uninfected individuals which also involves a structural reorganization in the overall working environment and clinical practices during COVID-19 pandemic. It requires a joint effort from all health care professionals involved in patient care in the ophthalmology department.

      It was evident that even subclinical patients can transmit the infection [28]. A well-planned system of triaging at different levels of patient care will help to achieve this in an effective manner [20]. Patients who won’t be adversely affected by postponing their routine OPD visit need to be identified, segregate and informed accordingly depending upon their disease condition. This can be done by contacting them through Short Message Service (SMS), text message services or even calling personally and passing the information at least a week prior to their scheduled appointment. They may be provided with an enquiry number through which necessary information about rescheduling an appointment as well as consideration of a drug-refill if appropriate, may be enquired.

      Tele services play an important role in delivering patient care in this scenario. The use of tele medicine in ophthalmology was first described in 1999 by HK Li and it is defined as the use of information technology to support healthcare between participants who are separated from each other [29,30].

      Suspending elective services and surgeries will add on to the measures obtained to reduce transmission risk. Remote telephone-based interviews, video examination visits can be a good alternative for managing non-urgent patients and thereby avoid direct patient-physician close contacts.

      Installation of triage stations as first contact points help to scrutinize and screen patients as well as attenders. Emerging studies show that most of the COVID-19 cases present with fever as their primary symptom [31]. These stations should be equipped for symptomatic screening of all individuals visiting the OPD.

      Additionally, a questionnaire-based triaging will help to further identify individuals with possible history of contact with COVID-19 positive cases and can be screened, segregate, and examined separately. This includes enquiry about symptoms suggestive of fever, upper or lower respiratory tract infection (cough, sore throat, running nose, breathlessness), history of any family members or close contacts suffering from same symptoms, any history of travel to covid outbreak areas in past 14 days etc. (Figure 1). The case classification scheme launched by WHO which triaged patients into healthy, suspect, probable and confirmed COVID-19 categories may be made use of for the same [32].

Figure 1: Questionnaire for screening patients in COVID-19 Pandemic.

      Attenders accompanying patients should be discouraged as far as possible except in unavoidable cases to prevent overcrowding. Social distancing in waiting areas as well as in front of registration desks or dispensaries can be ensured by blocking alternate seats or a set of seats with the help of suitable “cross mark” indicator stickers. Markings on floor to indicate positions that must be occupied to maintain social distancing while standing in a queue also helps to prevent cross infection to a significant extend.

      Workflow systems made in the form of flow charts will ease out the triaging system and display of the same in relevant areas of patient segregation helps the supporting staff to adopt into such a revised working pattern (Figure 2).

Figure 2: Flow chart of a revised functioning strategy in Ophthalmology clinic in COVID-19 Pandemic.

      Separate rooms with complete set of ophthalmological instruments in duplication will help prevent intermingling of the patients once triaged. Ophthalmological instruments in which barrier protection may be installed can be improvised accordingly to prevent direct aerosol transmission form patient to the examining physician (Figure 3).

Figure 3: "Barrier Shield" - Improvisation on a slit lamp biomicroscope.

      Workers should be divided into small and fixed teams and made to work in separate shifts in these pre-assigned rooms. Handing taking over between these teams should be minimized, performed in a virtual manner wherever possible and should be conducted with adequate personal protective measures taken by both teams.

      Separate imaging rooms with allocation of a set of instruments in isolated rooms will help to minimize contacts. Suspected staff members based on contact with confirmed patients or on becoming symptomatic needs to be quarantined and tested to rule out SARS-CoV-2 infection. With the advent of vaccination, all health care professionals associated with routine patient care should be immunized on priority.

4. Specific measures

      Specific measures may be adopted on a case-to-case basis depending upon various subspecialities in ophthalmology. Telemedicine is widely be used in pediatric ophthalmology services in the form of Retinopathy Of Prematurity (ROP) screening, screening for amblyopia, refraction and strabismus. With the help of many web-based applications, follow up can be done based on sharing videos of various examinations that can be performed by guardians and thus postponing follow-up appointments in such conditions where vision is not at risk. Surgeries in pediatric age group needs extra caution since most of them are done in general anesthesia which required endotracheal intubation that may result in aerosol generation and cross infection.

      Retina clinics have elderly group of individuals as majority who are vulnerable and suffers from some comorbidities. Categorization based on urgency of management may be applied here also. Sight-threatening conditions like trauma, retinal detachments and vitreous hemorrhage would benefit from urgent evaluation and prompt intervention in separate rooms designated for examination of unscreened patients. Anti-Vascular Endothelial Growth Factor (VEGF) therapy is provided under a modified regimen [33-35]. Patients under monthly intravitreal injections can be called on appointment basis keeping their number to a minimum. Clinical examination can be postponed, diagnosis may be made based on Optical Coherence Tomography (OCT) images and fundus photography images which can be reviewed by the retina specialist at home with a remote connection and decision regarding the interval of injections for each patient following a “treat and extend” protocol can be given. Telemedicine is an innovative solution for evaluation of other retinal abnormalities such as acute floaters, Age Related Macular Degeneration (ARMD) and Diabetic Retinopathy (DR).

      Cornea service can also be provided by telemedicine consultation by the doctor where the patient is asked about symptoms such as diminution of vision, photophobia, pain, redness, discharge, and pictures taken using their smartphones can also be asked for. However, an objective evaluation using a slit lamp and other modalities would be a limiting factor. Cases requiring urgent review at the cornea clinic including corneal ulcers, corneal perforation or melt, foreign body necessitating removal and keratitis could be instructed to review at the clinic by taking adequate personal protective measures on appointment. Patients having active posterior or pan uveitis or complications of uveitis like Cystoid Macular Edema (CME), inflammatory Choroidal Neo Vascular Membrane (CNVM) require visit to the clinic. Imaging modalities such as SSOCT and fundus cameras can be used for accurate documentation of the posterior segment findings.

      Cancellation or postponement of non-urgent cataract surgeries can reduce the risk of viral transmission, outweighing the surgical benefits of cataract surgery [37]. Telemedicine may be used to follow up patients who underwent cataract surgery. Frequency of follow up can be reduced compared to the routine follow up schedule as it used to be during the pre-corona days. Visual acuity may be assessed by taking reviews from patients telephonically after training them to assess the same by digital assessment charts. For screening and monitoring patients of glaucoma, evaluation in the form of Intraocular Pressure (IOP), corneal thickness, anterior chamber depth, morphology of angle structures, optic disc changes, visual field analysis and RNFL thickness can be done by trained technicians; parameters measured remotely at the clinics and sent to the treating physician, thereby minimizing patient-doctor encounters. Tele-glaucoma may be used to follow up non urgent cases in whom optimization of medical management has already been achieved [37].

      Transmission of SARS-CoV-2 through mucus membranes is already established [38]. Viruses enter the tears through droplets, which may then pass through nasolacrimal duct to enter nasal mucosa and thereafter to other parts of the respiratory tract [39]. In this context a high suspicion of probability of cross infection through trial sets and contact lenses should be considered. Hence, optometry services, contact lens and refraction clinics need to be closed and services providing biometry tests for urgent surgeries should only be made functional during this global pandemic.

Conclusion

      Covid-19 has paralyzed the health care system globally and understanding of the true impact helps to strategize, plan and allocate work force and resources during the post Covid-19 period, ultimately minimizing any harm to patient’s vision and quality of life [40].

      The circumstances of this pandemic are unprecedented, but our global community does have experience that is applicable. Though the impact of covid-19 has been uneven and is rapidly changing, these insights can help unify our response and preserve vision. In global ophthalmology, a broad enough perspective to overcome any problems has been developed over years [41].

      Due to uncertainty of the disease transmission, strict adherence to safety guidelines should be always followed. The guidelines include proper donning of PPE, proper disinfection of ophthalmic equipment, thorough screening, and triage prior to appointment, on the day of evaluation at the clinic and while performing clinical examination of the patient. With continued efforts focusing on reduction of transmission by following proper safety guidelines, we strive toward the goal of offering safe and quality ophthalmological care.

References

  1. Li W. Coronavirus kills Chinese Whistleblower Doctor. 2020.
  2. Lai TH, Tang EW, Chau SK, Fung KS, Li KK. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: An experience from Hong Kong. Graefe's Archive for Clinical and Experimental Ophthalmology. 2020; 258: 1049-1055.
  3. Li JP, Shantha J, Wong TY, Wong EY, Mehta J, et al. Preparedness among ophthalmologists: During and beyond the COVID-19 pandemic. Ophthalmology. 2020; 127: 569-572.
  4. Foot B and MacEwen C. Surveillance of sight loss due to delay in ophthalmic treatment or review: Frequency, cause and outcome. Eye (Lond). 2017; 31: 771-775.
  5. Ting DS, Krause S, Said DG, Dua HS. Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK. Eye. 2021; 35: 2064-2066.
  6. Peng Y, Zhou YH. Is novel coronavirus disease (COVID-19) transmitted through conjunctiva? J Med Virol. 2020.
  7. Li JO, Lam DSC, Chen Y, Ting DSW. Novel coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol. 2020; 104: 297-298.
  8. Romano MR, Montericcio A, Montalbano C, Raimondi R, Allegrini D, et al. Facing COVID-19 in ophthalmology department. Curr Eye Res. 2020; 45: 653-658.
  9. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020; 94: e00127-e001320.
  10. Kaushik J, Singh A, Kochhar D, Murari T, Shetty R. and Parihar, J.K.S. (2021), Receptors modulation on the ocular surface: A novel insight into the ocular infection and disease transmission of SARS-COV-2. J Med Virol, 93: 2614-2615. 
  11. Seitzman GD, Doan T. No time for tears. Ophthalmology 2020.
  12. Loon SC, Teoh SC, Oon LL, Se-Thoe SY, Ling AE, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004; 88: 861-863.
  13. Ministry of Health (MOH) Singapore Environmental cleaning guidelines for healthcare settings Singapore. 2013.
  14. Dancer SJ (1999) Mopping up hospital infection. J Hosp Infect. 1999; 43(2): 85-100.
  15. Boyce JM, Havill NL, Lipka A, Havill H, Rizvani R. Variations in hospital daily cleaning practices. Infection Control & Hospital Epidemiology. 2010; 31: 99-101.
  16. Bhalla A, Pultz NJ, Gries DM, Ray AJ, Eckstein EC, et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infection Control & Hospital Epidemiology. 2004; 25: 164-167.
  17. Hayden MK, Blom DW, Lyle EA, Moore CG, Weinstein RA. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment. Infection Control & Hospital Epidemiology. 2008; 29: 149-154.
  18. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection. Journal of medical virology. 2020; 92: 589-594.
  19. Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020; 395: E39.
  20. Lai TH, Tang EW, Chau SK, Fung KS, Li KK. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: An experience from Hong Kong. Graefe's Archive for Clinical and Experimental Ophthalmology. 2020; 258: 1049-1055.
  21. Seah I, Su X, Lingam G. Revisiting the dangers of the coronavirus in the ophthalmology practice. Eye. 2020; 16: 1-3.
  22. Chan WM, Liu DT, Chan PK, Chong KK, Yuen KS, et al. Precautions in ophthalmic practice in a hospital with a major acute SARS outbreak: An experience from Hong Kong. Eye. 2006; 20: 283-289.
  23. American Academy of Ophthalmology. Alert: Important coronavirus updates for ophthalmologists. 2020.
  24. The Israeli Ophthalmological Society. Guidelines and protection against COVID-19. Available. 2020.
  25. COVID-19: Resources for households, 2020/ 2020.
  26. Buornanno M, Welch D, Shuryak I, Brenner DJ. Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses. Sci Rep. 2020; 10: 10285.
  27. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: A systematic review. PloS one. 2012; 7: e35797.
  28. Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020.
  29. Li HK. Telemedicine and ophthalmology. Surv Ophthalmol. 1999; 44: 61-72.
  30. Field MJ. TELECOMMUNICATIONS in HEALTHCARE. 1997; 1: 1997.
  31. Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020.
  32. Global surveillance for human infection with coronavirus disease (COVID-19). 2020.
  33. American Academy of Ophthalmology. Coronavirus impact: practice operations and safety considerations. 2020.
  34. The American Society of Retina Specialists. ASRS releases guidelines to help retina practices navigate COVID-19 pandemic. 2020.
  35. Macular Society. Injection treatment: latest advice from the Royal College of ophthalmologists. 2020.
  36. CW L, Liu XF JZ. 2019-nCoV transmission through the ocular surface must not be ignored. The Lancet. 2020; 22: 10224.
  37. Coronavirus: Information for glaucoma patients/news. 2020.
  38. Liang L, Wu P. There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol. 2020: 443003.
  39. Qing H, Li Z, Yang Z, Shi M, Huang Z, et al. The possibility of COVID‐19 transmission from eye to nose. Acta ophthalmologica. 2020.
  40. Ting DS, Deshmukh R, Said DG, Dua HS. The impact of COVID-19 pandemic on ophthalmology services: Are we ready for the aftermath?. Therapeutic Advances in Ophthalmology. 2020.
  41. Hinkle JW, Ansari Z, Tabin GC. Global Ophthalmology Insights for a Global Pandemic. American Journal of Ophthalmology. 2020; 216: A9.

MedDocs Publishers

We always work towards offering the best to you. For any queries, please feel free to get in touch with us. Also you may post your valuable feedback after reading our journals, ebooks and after visiting our conferences.